We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VER
526
DELISTED
VEREIT, Inc.
VER
| $6.51M | 0.01% |
186,940
-82,040
| -31% | -$2.91M |
|
527
CenterPoint Energy
CNP
$26.8B
| $6.5M | 0.01% |
+237,100
| New | +$6.46M |
|
|
SHOE
528
Shoe Station Group
SHOE
$428M
| $6.46M | 0.01% |
542,718
+30,000
| +6% | +$361K |
|
|
ENIA
529
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $6.42M | 0.01% |
+552,870
| New | +$6.33M |
|
530
BlackRock TCP Capital
TCPC
$345M
| $6.37M | 0.01% |
448,073
-96,832
| -18% | -$1.42M |
|
531
Citi Trends
CTRN
$605M
| $6.34M | 0.01% |
205,124
+10,500
| +5% | +$257K |
|
|
CISN
532
DELISTED
Cision Ltd. Ordinary Share
CISN
| $6.27M | 0.01% |
+542,086
| New | +$6.44M |
|
533
WaFd
WAFD
$2.75B
| $6.23M | 0.01% |
179,972
-148,494
| -45% | -$5.27M |
|
534
ICF International
ICFI
$1.72B
| $6.2M | 0.01% |
106,147
-71,023
| -40% | -$4M |
|
|
EMBJ
535
Embraer S.A. ADS
EMBJ
$13B
| $6.14M | 0.01% |
236,038
-847,955
| -78% | -$22M |
|
536
Haemonetics
HAE
$4B
| $6.14M | 0.01% |
+83,870
| New | +$5.75M |
|
537
W.R. Berkley
WRB
$26.6B
| $6.1M | 0.01% |
+283,308
| New | +$5.91M |
|
538
McKesson
MCK
$101B
| $6.1M | 0.01% |
+43,300
| New | +$6.75M |
|
|
RFP
539
DELISTED
Resolute Forest Products Inc.
RFP
| $6.05M | 0.01% |
729,062
+287,522
| +65% | +$2.68M |
|
|
CTRA
540
DELISTED
Coterra Energy
CTRA
| $6.01M | 0.01% |
250,703
-653,607
| -72% | -$16.8M |
|
541
Hamilton Lane
HLNE
$5.57B
| $6M | 0.01% |
161,288
-72,575
| -31% | -$2.67M |
|
542
TransDigm Group
TDG
$67.7B
| $5.99M | 0.01% |
+19,500
| New | +$5.75M |
|
543
ServiceNow
NOW
$129B
| $5.97M | 0.01% |
+180,500
| New | +$5.57M |
|
544
Teledyne Technologies
TDY
$32B
| $5.9M | 0.01% |
+31,500
| New | +$5.95M |
|
545
Saia
SAIA
$9.72B
| $5.8M | 0.01% |
77,200
+45,300
| +142% | +$3.37M |
|
546
Hubbell
HUBB
$27.2B
| $5.74M | 0.01% |
+47,100
| New | +$6.2M |
|
547
Corpay
CPAY
$25.7B
| $5.7M | 0.01% |
+28,162
| New | +$5.71M |
|
|
VSM
548
DELISTED
Versum Materials, Inc.
VSM
| $5.63M | 0.01% |
149,554
-844,794
| -85% | -$32.2M |
|
549
Bloomin' Brands
BLMN
$938M
| $5.6M | 0.01% |
230,823
+173,411
| +302% | +$3.93M |
|
550
QuinStreet
QNST
$1.21B
| $5.6M | 0.01% |
438,844
-16,475
| -4% | -$193K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.